These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12682321)

  • 1. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.
    Hyman SL; Gill DS; Shores EA; Steinberg A; Joy P; Gibikote SV; North KN
    Neurology; 2003 Apr; 60(7):1139-45. PubMed ID: 12682321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.
    Hyman SL; Gill DS; Shores EA; Steinberg A; North KN
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1088-91. PubMed ID: 17299016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year study.
    Payne JM; Pickering T; Porter M; Oates EC; Walia N; Prelog K; North KN
    Am J Med Genet A; 2014 Mar; 164A(3):661-5. PubMed ID: 24357578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: Are T2-weighted hyperintensities related to executive dysfunction?
    Roy A; Barbarot S; Charbonnier V; Gayet-Delacroix M; Stalder JF; Roulin JL; Le Gall D
    Neuropsychology; 2015 May; 29(3):473-84. PubMed ID: 25365565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities.
    Feldmann R; Denecke J; Grenzebach M; Schuierer G; Weglage J
    Neurology; 2003 Dec; 61(12):1725-8. PubMed ID: 14694037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1.
    Feldmann R; Schuierer G; Wessel A; Neveling N; Weglage J
    Acta Paediatr; 2010 Nov; 99(11):1657-60. PubMed ID: 21039823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study.
    Sabol Z; Resić B; Gjergja Juraski R; Sabol F; Kovac Sizgorić M; Orsolić K; Ozretić D; Sepić-Grahovac D
    Croat Med J; 2011 Aug; 52(4):488-96. PubMed ID: 21853543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
    Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
    Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis.
    Moore BD; Slopis JM; Schomer D; Jackson EF; Levy BM
    Neurology; 1996 Jun; 46(6):1660-8. PubMed ID: 8649566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning.
    Piscitelli O; Digilio MC; Capolino R; Longo D; Di Ciommo V
    Dev Med Child Neurol; 2012 Jan; 54(1):49-51. PubMed ID: 22107256
    [No Abstract]   [Full Text] [Related]  

  • 12. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
    Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
    Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal Cord Hyperintensities in Neurofibromatosis Type 1: Are They the Cord Equivalent of Unidentified Bright Objects in the Brain?
    Rüegger AD; Coleman L; Hansford JR; McLean N; Dabscheck G
    Pediatr Neurol; 2018 Sep; 86():63-65. PubMed ID: 30174245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
    Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
    Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL.
    Viswanathan A; Gschwendtner A; Guichard JP; Buffon F; Cumurciuc R; O'Sullivan M; Holtmannspötter M; Pachai C; Bousser MG; Dichgans M; Chabriat H
    Neurology; 2007 Jul; 69(2):172-9. PubMed ID: 17620550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Key Search Subtest of the Behavioural Assessment of the Dysexecutive Syndrome in Children (BADS-C) Instrument Reveals Impaired Planning Without External Constraints in Children With Neurofibromatosis Type 1.
    Riva D; Vago C; Erbetta A; Saletti V; Esposito S; Micheli R; Bulgheroni S
    J Child Neurol; 2017 Mar; 32(4):387-396. PubMed ID: 28193119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results.
    Parmeggiani A; Boiani F; Capponi S; Duca M; Angotti M; Pignataro V; Sacrato L; Spinardi L; Vara G; Maltoni L; Cecconi I; Pastore Trossello M; Franzoni E
    Eur J Paediatr Neurol; 2018 Sep; 22(5):822-830. PubMed ID: 29802023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related findings on MRI in neurofibromatosis type 1.
    Gill DS; Hyman SL; Steinberg A; North KN
    Pediatr Radiol; 2006 Oct; 36(10):1048-56. PubMed ID: 16912896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1.
    Joy P; Roberts C; North K; de Silva M
    Dev Med Child Neurol; 1995 Oct; 37(10):906-14. PubMed ID: 7493724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression.
    Kramer-Ginsberg E; Greenwald BS; Krishnan KR; Christiansen B; Hu J; Ashtari M; Patel M; Pollack S
    Am J Psychiatry; 1999 Mar; 156(3):438-44. PubMed ID: 10080561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.